Skip Navigation


Carcinogenesis Advance Access originally published online on March 7, 2007
Carcinogenesis 2007 28(8):1831-1838; doi:10.1093/carcin/bgm053
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
28/8/1831    most recent
bgm053v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (6)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Koturbash, I.
Right arrow Articles by Kovalchuk, O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Koturbash, I.
Right arrow Articles by Kovalchuk, O.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2007. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Role of epigenetic effectors in maintenance of the long-term persistent bystander effect in spleen in vivo

Igor Koturbash{dagger}, Alex Boyko{dagger}, Rocio Rodriguez-Juarez, Robert J. McDonald1, Volodymyr P. Tryndyak2, Igor Kovalchuk, Igor P. Pogribny2 and Olga Kovalchuk*

Department of Biological Sciences
1 Department of Neuroscience, University of Lethbridge, Alberta, T1K 3M4, Canada
2 Division of Biochemical Toxicology, National Center for Toxicological Research, Jefferson, AR 72079, USA

* To whom correspondence should be addressed. Tel: 1 403 394 3916; Fax: 1 403 329 2242; Email: olga.kovalchuk{at}uleth.ca

Radiation therapy is a primary treatment modality for brain tumors, yet it has been linked to the increased incidence of secondary, post-radiation therapy cancers. These cancers are thought to be linked to indirect radiation-induced bystander effect. Bystander effect occurs when irradiated cells communicate damage to nearby, non-irradiated ‘bystander’ cells, ultimately contributing to genome destabilization in the non-exposed cells. Recent evidence suggests that bystander effect may be epigenetic in nature; however, characterization of epigenetic mechanisms involved in bystander effect generation and its long-term persistence has yet to be defined. To investigate the possibility that localized X-ray irradiation induces persistent bystander effects in distant tissue, we monitored the induction of epigenetic changes (i.e. alterations in DNA methylation, histone methylation and microRNA (miRNA) expression) in the rat spleen tissue 24 h and 7 months after localized cranial exposure to 20 Gy of X-rays. We found that localized cranial radiation exposure led to the induction of bystander effect in lead-shielded, distant spleen tissue. Specifically, this exposure caused the profound epigenetic dysregulation in the bystander spleen tissue that manifested as a significant loss of global DNA methylation, alterations in methylation of long interspersed nucleotide element-1 (LINE-1) retrotransposable elements and down-regulation of DNA methyltransferases and methyl-binding protein methyl CpG binding protein 2 (MeCP2). Further, irradiation significantly altered expression of miR-194, a miRNA putatively targeting both DNA methyltransferase-3a and MeCP2. This study is the first to report conclusive evidence of the long-term persistence of bystander effects in radiation carcinogenesis target organ (spleen) upon localized distant exposure using the doses comparable with those used for clinical brain tumor treatments.

Abbreviations: DNMT, DNA methyltransferase; IR, ionizing radiation; LINE-1, long interspersed nucleotide element-1; MeCP2, methyl CpG binding protein 2; miRNA, microRNA; ORF1, open reading frame 1; PCNA, proliferating cell nuclear antigen; PCR, polymerase chain reaction; RT, reverse transcription


{dagger} These authors contributed equally to this work

Received August 10, 2006; revised February 23, 2007; accepted March 2, 2007.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.